unknown
Stage
About
Gefjon Pharma develops innovative OMV-based vaccine technology, including a broad-spectrum aerosol E. coli vaccine for poultry, aiming to provide scalable, cost-effective biologics for veterinary and human medicine.
Explore Gefjon Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.